A detailed history of Lee Ainslie (Maverick Capital LTD) transactions in Mckesson Corp stock. As of the latest transaction made, Maverick Capital LTD holds 888 shares of MCK stock, worth $521,930. This represents 0.01% of its overall portfolio holdings.

Number of Shares
888
Previous 969 8.36%
Holding current value
$521,930
Previous $448,000 6.25%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$473.42 - $539.26 $38,347 - $43,680
-81 Reduced 8.36%
888 $476,000
Q4 2023

Feb 14, 2024

BUY
$437.42 - $470.64 $423,859 - $456,050
969 New
969 $448,000
Q2 2023

Aug 14, 2023

BUY
$354.01 - $427.31 $328,875 - $396,970
929 New
929 $396,000
Q4 2021

Feb 14, 2022

SELL
$198.21 - $248.9 $866,375 - $1.09 Million
-4,371 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$188.42 - $208.66 $780,812 - $864,687
4,144 Added 1825.55%
4,371 $871,000
Q2 2021

Aug 16, 2021

BUY
$184.89 - $202.68 $20,707 - $22,700
112 Added 97.39%
227 $43,000
Q1 2021

May 17, 2021

SELL
$169.52 - $196.53 $20,850 - $24,173
-123 Reduced 51.68%
115 $22,000
Q4 2020

Feb 16, 2021

SELL
$143.79 - $183.66 $1.87 Million - $2.39 Million
-13,000 Reduced 98.2%
238 $41,000
Q3 2020

Nov 16, 2020

BUY
$140.89 - $159.9 $208,798 - $236,971
1,482 Added 12.61%
13,238 $1.97 Million
Q2 2020

Aug 14, 2020

BUY
$125.49 - $164.68 $1.17 Million - $1.53 Million
9,286 Added 375.95%
11,756 $1.8 Million
Q1 2020

May 15, 2020

BUY
$115.75 - $170.96 $285,902 - $422,271
2,470 New
2,470 $334,000
Q4 2019

Feb 14, 2020

SELL
$130.23 - $153.27 $4.86 Million - $5.72 Million
-37,343 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$134.24 - $148.53 $5.01 Million - $5.55 Million
37,343 New
37,343 $5.1 Million

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $84.5B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track Lee Ainslie's Portfolio

Track Lee Ainslie Portfolio

Follow Lee Ainslie (Maverick Capital LTD) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.